Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: Aquavan®; Fospropofol disodium; GPI 15715; HX0507; Lusedra; PQ 1002

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ProQuest Pharmaceuticals
  • Developer Eisai Co Ltd; West China Hospital Sichuan University; Yichang Humanwell Pharmaceutical
  • Class Anaesthetics; Hypnosedatives; Phenols; Small molecules
  • Mechanism of Action GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Sedation

Most Recent Events

  • 12 Feb 2018 Yichang Humanwell Pharmaceutical in collaboration with West China Hospital, Sichuan University completed a phase III trial in Sedation (In volunteers) in China (ChiCTR1800016329)
  • 19 Jan 2018 Yichang Humanwell Pharmaceutical in collaboration with Sichuan University completes a phase III trial in Sedation (In volunteers) in China (ChiCTR1800016410)
  • 20 Dec 2017 Phase-III clinical trials in Sedation (In volunteers) in China (IV) (ChiCTR1800016329)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top